- Investing Ideas
- /
- Household Healthcare Sector
Household Healthcare Sector
Results
2306
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2306 companies
Metagenomi
Market Cap: US$63.5m
A genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States.
MGX
US$1.65
7D
10.0%
1Y
-77.0%
OKYO Pharma
Market Cap: US$62.8m
A clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom.
OKYO
US$1.65
7D
23.1%
1Y
10.5%
Kalaris Therapeutics
Market Cap: US$62.3m
A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.
KLRS
US$2.98
7D
-11.8%
1Y
n/a
Nutriband
Market Cap: US$62.2m
Develops a portfolio of transdermal pharmaceutical products.
NTRB
US$5.36
7D
-5.0%
1Y
10.1%
Adicet Bio
Market Cap: US$62.0m
A clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.
ACET
US$0.70
7D
8.5%
1Y
-57.1%
Applied Therapeutics
Market Cap: US$61.7m
A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.
APLT
US$0.38
7D
-22.1%
1Y
-91.0%
Skye Bioscience
Market Cap: US$61.0m
A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.
SKYE
US$2.21
7D
16.3%
1Y
-81.6%
Context Therapeutics
Market Cap: US$60.9m
A biopharmaceutical company, develops products for the treatment of solid tumors.
CNTX
US$0.69
7D
-12.5%
1Y
-64.6%
INSPECS Group
Market Cap: UK£45.2m
Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia.
SPEC
UK£0.45
7D
2.3%
1Y
-37.8%
Medexus Pharmaceuticals
Market Cap: CA$83.2m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.64
7D
5.6%
1Y
65.0%
NeueHealth
Market Cap: US$60.0m
A healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States.
NEUE
US$6.76
7D
-1.1%
1Y
13.5%
Vitrafy Life Sciences
Market Cap: AU$92.6m
Provides cryopreservation solutions in Australia.
VFY
AU$1.50
7D
-9.9%
1Y
n/a
Cyberfuels Holding
Market Cap: US$59.6m
Operates as an energy and healthcare company in the United States.
CBRF
US$0.52
7D
-10.4%
1Y
-38.9%
Verrica Pharmaceuticals
Market Cap: US$59.5m
A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.
VRCA
US$0.64
7D
19.1%
1Y
-93.0%
Creo Medical Group
Market Cap: UK£44.3m
Through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments in the United Kingdom.
CREO
UK£0.11
7D
7.3%
1Y
-69.2%
Retrieve Medical Holdings
Market Cap: US$59.2m
Develops software solutions related to data mining, clinical decision support, natural language processing, and algorithmic testing for analyzing patient’s accumulated medical records and lab results in medical center emergency departments.
RMHI
US$2.18
7D
-37.9%
1Y
-51.7%
SkinBioTherapeutics
Market Cap: UK£44.0m
A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.
SBTX
UK£0.19
7D
-4.4%
1Y
83.3%
Biomea Fusion
Market Cap: US$59.0m
A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.
BMEA
US$1.45
7D
-0.7%
1Y
-87.4%
Arovella Therapeutics
Market Cap: AU$91.2m
A biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally.
ALA
AU$0.072
7D
-11.1%
1Y
-34.5%
Medinotec
Market Cap: US$58.7m
Engages in the research and development, production, and sale of medical devices in South Africa, the United States, and internationally.
MDNC
US$5.00
7D
0%
1Y
n/a
Immix Biopharma
Market Cap: US$58.5m
A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.
IMMX
US$2.09
7D
5.6%
1Y
-2.8%
Repare Therapeutics
Market Cap: US$58.2m
A clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.
RPTX
US$1.32
7D
1.1%
1Y
-60.0%
Mach7 Technologies
Market Cap: AU$90.0m
Provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally.
M7T
AU$0.38
7D
2.7%
1Y
-43.6%
P3 Health Partners
Market Cap: US$57.7m
A patient-centered and physician-led population health management company, provides superior care services in the United States.
PIII
US$7.81
7D
-4.5%
1Y
-68.9%
IceCure Medical
Market Cap: US$57.7m
A commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.
ICCM
US$1.03
7D
3.0%
1Y
-2.8%
Vicapsys Life Sciences
Market Cap: US$57.3m
Focuses on the development and commercialization of VICAPSYN, a proprietary product.
VICP
US$1.77
7D
0%
1Y
298.6%
Actinium Pharmaceuticals
Market Cap: US$57.1m
Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.
ATNM
US$1.71
7D
17.1%
1Y
-80.3%
Outlook Therapeutics
Market Cap: US$57.1m
Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.
OTLK
US$1.63
7D
-6.6%
1Y
-79.6%
Serina Therapeutics
Market Cap: US$56.9m
A biotechnology company, develops drugs to treat neurological diseases and pain.
SER
US$5.41
7D
-3.6%
1Y
-41.8%
ECO Animal Health Group
Market Cap: UK£42.3m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.63
7D
0%
1Y
-46.1%
Gemina Laboratories
Market Cap: CA$78.8m
A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.
GLAB
CA$1.02
7D
14.6%
1Y
117.0%
Immuneering
Market Cap: US$56.5m
A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.
IMRX
US$1.48
7D
17.5%
1Y
-4.5%
Apyx Medical
Market Cap: US$56.3m
An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
APYX
US$1.48
7D
5.0%
1Y
-7.5%
Vivos
Market Cap: US$56.1m
A radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States.
RDGL
US$0.12
7D
-12.2%
1Y
-20.2%
HeartBeam
Market Cap: US$56.0m
Operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.
BEAT
US$1.58
7D
-1.3%
1Y
-33.1%
United Health Products
Market Cap: US$55.9m
Develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States.
UEEC
US$0.21
7D
-11.1%
1Y
21.6%